DWJ-1248

N/A

Report date: 2024/11/07 11:09:04
NME

Base Information

Drug NameDWJ-1248
Drug Alias NameDWJ-1248DWJ1248
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPeptide hydrolase inhibitors
TargetsPeptide hydrolase
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesDaewoong Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesDaewoong Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsCoronavirus Disease 2019 (COVID-19)

Other Information

ATC CodeN/A
Related LinksN/A